Insights Blog
Explore our thought leadership insights, as life science technologies evolve and accelerate.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Newsletter Update
Investors
Healthcare Investment | August Roundup 2026
August 2026 was defined by aggressive deal-making in metabolic disease, radiopharmaceuticals, rare diseases, and a historic wave of biotech IPOs that collectively raised over $1.2 billion in a single week.
September 1, 2026

Newsletter Update
Investors
Healthcare Investment | August Roundup 2026
August 2026 was defined by aggressive deal-making in metabolic disease, radiopharmaceuticals, rare diseases, and a historic wave of biotech IPOs that collectively raised over $1.2 billion in a single week.
September 1, 2026
Precision Medicine
DeciBio Ventures
Private Equity

DeciBio Q&A
Pharma
Patient Data and the Barriers to Its Potential: DeciBio Q&A with Blanca Baez, Founder at DBounce
In this DeciBio Q&A, Blanca Baez, founder of DBounce, reflects on two decades in pharma, biotech, and AI-driven R&D to discuss the evolving role of patient data.
August 27, 2026

DeciBio Q&A
Pharma
Patient Data and the Barriers to Its Potential: DeciBio Q&A with Blanca Baez, Founder at DBounce
In this DeciBio Q&A, Blanca Baez, founder of DBounce, reflects on two decades in pharma, biotech, and AI-driven R&D to discuss the evolving role of patient data.
August 27, 2026
AI / Machine Learning
Women in Leadership
Clinical Diagnostics

Newsletter Update
Diagnostics
Liquid Biopsy | July Round-Up 2026
Liquid Biopsy (LBx) continued to develop through July, featuring a big acquisition, new regulatory approvals, and study results.
August 13, 2026

Newsletter Update
Diagnostics
Liquid Biopsy | July Round-Up 2026
Liquid Biopsy (LBx) continued to develop through July, featuring a big acquisition, new regulatory approvals, and study results.
August 13, 2026
Liquid Biopsy

Webinar
Diagnostics
Digital Pathology at a Crossroads: Consolidation, Clinical Integration, and What Comes Next Webinar
Join us for a forward-looking discussion on the scientific, clinical, and strategic forces shaping the future of digital pathology as a precision medicine tool.
August 13, 2026

Webinar
Diagnostics
Digital Pathology at a Crossroads: Consolidation, Clinical Integration, and What Comes Next Webinar
Join us for a forward-looking discussion on the scientific, clinical, and strategic forces shaping the future of digital pathology as a precision medicine tool.
August 13, 2026
Clinical Diagnostics
Diagnostics Market
Digital Pathology
pharma

Newsletter Update
Investors
Healthcare Investment | Mid-Year Roundup 2026
Biopharma's first half of 2026 saw its strongest dealmaking since before the pandemic — over $130B in M&A across 30+ billion-dollar deals.
August 11, 2026

Newsletter Update
Investors
Healthcare Investment | Mid-Year Roundup 2026
Biopharma's first half of 2026 saw its strongest dealmaking since before the pandemic — over $130B in M&A across 30+ billion-dollar deals.
August 11, 2026
Precision Medicine
DeciBio Ventures
Private Equity
Precision Medicine is evolving at a rapid pace
Discover how we can help
Get in Touch
© DeciBio 2023 | All rights reserved

.png)


